Mounjaro 10 mg
  1. Home
  2. Mounjaro
  3. Mounjaro 10 mg

Mounjaro 10 mg

Mounjaro 10 mg is a prescription dual GIP and GLP-1 receptor agonist containing tirzepatide, used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is administered as a once-weekly subcutaneous injection using a sterile prefilled injection pen. The 10 mg strength is commonly prescribed as part of maintenance therapy after gradual dose escalation.

BUY NOW

Category

Mounjaro 10 mg contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood glucose and body weight by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The 10 mg dose is typically prescribed after progressive dose escalation to provide sustained metabolic control and support long-term treatment goals when clinically appropriate. Manufactured under stringent pharmaceutical quality standards, the sterile prefilled injection pen is engineered for precise subcutaneous administration and dependable clinical performance. Mounjaro 10 mg should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Mounjaro 10 mg
Active Ingredient Tirzepatide
Strength 10 mg
Dosage Form Sterile Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Mounjaro 10 mg, Tirzepatide 10 mg, Mounjaro Injection Pen, Tirzepatide Prefilled Pen, Weekly Tirzepatide Injection, GIP GLP-1 Receptor Agonist, Diabetes Injection Pen